C. Granger, T. Subhawong, G. D'Amato, Emily E. Jonczak, Erika L. Garbrecht, S. Conway, J. Trent
{"title":"培西达替尼和CSF1R抑制剂治疗腱鞘巨细胞瘤","authors":"C. Granger, T. Subhawong, G. D'Amato, Emily E. Jonczak, Erika L. Garbrecht, S. Conway, J. Trent","doi":"10.17925/OHR.2021.16.2.119","DOIUrl":null,"url":null,"abstract":"<p />","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Pexidartinib and CSF1R Inhibitors as Treatment for Tenosynovial Giant Cell Tumors\",\"authors\":\"C. Granger, T. Subhawong, G. D'Amato, Emily E. Jonczak, Erika L. Garbrecht, S. Conway, J. Trent\",\"doi\":\"10.17925/OHR.2021.16.2.119\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p />\",\"PeriodicalId\":87332,\"journal\":{\"name\":\"Oncology & hematology review\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology & hematology review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/OHR.2021.16.2.119\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology & hematology review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/OHR.2021.16.2.119","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}